1. Home
  2. BRCC vs ADCT Comparison

BRCC vs ADCT Comparison

Compare BRCC & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BRC Inc.

BRCC

BRC Inc.

HOLD

Current Price

$8.44

Market Cap

152.1M

ML Signal

HOLD

Logo ADC Therapeutics SA

ADCT

ADC Therapeutics SA

HOLD

Current Price

$1.14

Market Cap

136.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRCC
ADCT
Founded
2014
2011
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
152.1M
136.1M
IPO Year
2022
2019

Fundamental Metrics

Financial Performance
Metric
BRCC
ADCT
Price
$8.44
$1.14
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$2.25
$7.75
AVG Volume (30 Days)
566.6K
1.8M
Earning Date
05-04-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
30.86
EPS
N/A
N/A
Revenue
$398,263,000.00
$81,357,000.00
Revenue This Year
$9.68
N/A
Revenue Next Year
$9.59
$66.49
P/E Ratio
N/A
N/A
Revenue Growth
1.73
14.85
52 Week Low
$0.60
$0.78
52 Week High
$10.65
$4.98

Technical Indicators

Market Signals
Indicator
BRCC
ADCT
Relative Strength Index (RSI) 77.07 46.53
Support Level $0.92 $1.03
Resistance Level $10.65 $1.20
Average True Range (ATR) 0.60 0.08
MACD 0.09 0.02
Stochastic Oscillator 76.98 42.67

Price Performance

Historical Comparison
BRCC
ADCT

About BRCC BRC Inc.

BRC Inc is a veteran-controlled company that serves premium coffee, content, and merchandise to active military, veterans, and first responders. It is committed to producing great coffee that consumers love, and high-quality merchandise that enables its community to showcase its brand. Its omnichannel distribution has three components: Direct to Consumer channel includes its e-commerce business, through which consumers order products online and products are shipped to them, Its wholesale channel includes products sold to an intermediary such as convenience, grocery, drug, and mass merchandise stores, who in turn sell those products to consumers, and Outpost channel includes revenue from its Company-operated and franchised Black Rifle Coffee retail coffee shop locations.

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. Additionally, the company's development pipeline comprises LOTIS-2, LOTIS-5, LOTIS-7, and ADCT-241, being developed as potential therapies for different cancer diseases. Geographically, the firm generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

Share on Social Networks: